Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 25-36 of 640 results.
"Ganciclovir via OPAT is a viable option in patients requiring an extended duration of IV therapy. In our cohort of 18 patients, only one had early discontinuation of therapy due to ganciclovir-related AKI. Close monitoring of labs and an established OPAT protocol can allow for successful completion of therapy" Patel et al (2025).
"We report two cases: one of neonatal hydrothorax with subsequent lung cystic formation after a parenteral nutrition leakage caused by the displacement of an Epicutaneo-Caval Catheter in the basilic vein of the left arm; the second involves a peritoneal collection of parenteral nutrition from the umbilical venous catheter" Coramusi et al (2025).
"There is a marginal loss of growth for every hour a blood culture is left unincubated, with the loss of recovery of Streptococcus pyogenes and other streptococci being most common. There was no evidence of a reduction in Gram-negatives, anaerobes, or yeasts" Deas et al (2025).
"This study aimed to assess the implementation and organization of Outpatient Parenteral Antimicrobial Therapy (OPAT) in France by examining the practices of community nurses (CNs)" Raux et al (2025).
"We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital" Gamage et al (2025).
"Specifically, studies that decrease the treatment length or advocate for the early transition of intravenous to oral antibiotics in all neonates with suspected or culture-positive sepsis or pneumonia should be regarded with caution" Lawrence et al (2025).
"A recent scoping review discovered a significant deficit in the literature covering clinical aspects of vascular access device (VAD) selection, insertion, and, in particular, training and education. To answer some of these questions, we are conducting a quantitative survey throughout Europe to investigate healthcare professionals' current practices surrounding vascular access devices used for systemic anti-cancer therapy" Duggan et al (2025).
"EJV access offers reduced operative time without increasing complication risk compared to IJV access for TIVAP placement in children. It may be preferred when minimizing anesthesia exposure is important" Hamzah et al (2025).
"Phlebitis incidence remains above recommended levels. Multivariable analysis identified female sex, a higher number of infused medications, older patient age, larger hospital size, and longer PIVC dwell time as the main independent predictors of phlebitis" Cernuda-Martínez et al (2025).
"These data suggest that the tibial and humeral IO routes of first epinephrine administration were associated with marginally prolonged resuscitation duration after drug administration and decreasing hazard of ROSC" Hubble et al (2025).
"This study showed that ipsilateral or contralateral placement did not affect the distance between CVC and CVDC line tips. There were no significant adverse changes in cardiovascular parameters or noradrenaline dose when CRRT was commenced regardless of whether the lines were inserted ipsilaterally or contralaterally" Hobson et al (2025).
"Tissue adhesives optimise VAD dressing by enhancing haemostasis, securement and infection control. This practice improves patient outcomes and reduces costs" Hitchcock and Almerol (2025).
